(CIDRAP News) An independent board that advises the US Department of Defense on science and technology issues issued a report on Election Day highlighting a range of priorities for the incoming Obama administration, including measures to prevent and respond to a bioterrorist attack.
(CIDRAP News) Two organizations recently reported winning US government contracts for research on drugs that could work against multiple bioterror-related diseases such as plague, tularemia, and anthrax.
(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.
(CIDRAP News) The president of the Association of Public Health Laboratories (APHL) complained to Congress last week that the federal program that monitors the air for dangerous pathogens in major cities is a heavy burden on state and local laboratories.